國立高雄大學圖資館 |

Language: English

Back

Competition law and policy in the Japanese pharmaceutical sector

Record Type:	Electronic resources : Monograph/item
Title/Author:	Competition law and policy in the Japanese pharmaceutical sectoredited by Akira Negishi, Masako Wakui, Naoko Mariyama.
other author:	Negishi, Akira.
Published:	Singapore :Springer Singapore :2022.
Description:	xxi, 245 p. :ill., digital ;24 cm.
Contained By:	Springer Nature eBook
Subject:	Antitrust lawJapan.
Online resource:	https://doi.org/10.1007/978-981-16-7814-1
ISBN:	9789811678141$q(electronic bk.)

Competition law and policy in the Japanese pharmaceutical sector
Competition law and policy in the Japanese pharmaceutical sector[electronic resource] /edited by Akira Negishi, Masako Wakui, Naoko Mariyama. - Singapore :Springer Singapore :2022. - xxi, 245 p. :ill., digital ;24 cm. - Kobe University monograph series in social science research,2524-5058. - Kobe University monograph series in social science research..

Preface -- PART I　HEALTHCARE AND PHARMACEUTICALS: INNOVATION AND REGULATION IN JAPAN -- Regulation and Competition in the Pharmaceutical Industry in Japan -- Competition and Cooperation: Building a Sustainable Healthcare Delivery System in a Society with a Declining Population -- Drug Regulation in Japan -- Collaboration between the Patent System and Pharmaceutical Regulations for Drug-discovery Innovation in Japan -- Corruption and Conflicts of Interest in the Pharmaceutical Market: Regulation of Pharmaceutical Companies' Gift-giving Practices -- PART II THE JAPANESE ANTIMONOPOLY ACT AND ITS RELATION TO THE PHARMACEUTICAL INDUSTRY -- Antimonopoly Act and Its Application to the Pharmaceutical Industry in Japan -- Horizontal Cooperation and Alliances amongst Pharmaceutical Companies and the Japanese Antimonopoly Act -- Merger Regulations in the Japanese Pharmaceutical Industry -- Pay-for-delay Agreements in Japan -- No Challenge Clauses in the Pharmaceutical Industry in Japan -- Will Authorised Biologics deter Biosimilars? -Utilising JFTC's expertise in drug pricing -- PART III AN ECONOMIC ANALYSIS OF THE PHARMACEUTICAL INDUSTRY AND TRADE PRACTICES IN JAPAN -- The Pharmaceutical Industry in Japan: A History of Its Development -- Trade Practices in the Japanese Pharmaceutical Market: A Simulation Analysis of Improvement Policies.

This is the first book published that focuses on competition law and policy in the Japanese pharmaceutical sector. It consists of chapters written and edited by academics who research the industry from various perspectives, including economics, competition law, pharmaceutical regulations, and intellectual property law. Competition policies involving pharmaceutical products attract attention from academics and policymakers worldwide. The pharmaceutical industry is regulated by drug laws that vary from country to country and are affected by differing practices and industrial structures. The book begins by examining drug regulations and trade practices in the industry that are peculiar to Japan and its healthcare system. It then presents the Japanese Antimonopoly Act and cases involving it, and discussions of current competition law issues in the Japanese pharmaceutical industry. The book also discusses innovation and intellectual property and economic analyses of pharmaceutical regulations and drug discovery. The chapters include comparative studies on Japanese regulations vs. those in the European Union and the United States. Japan is one of the biggest pharmaceutical markets in the world. With this in mind, the book provides "one-stop shopping" for anyone interested in pharmaceutical regulations in the country. Covering the basics but extending to in-depth explorations of complex problems, this book appeals not only to students and academics, pharmaceutical companies and regulators, but also to those dealing with real-world policy issues that encompass competition policy, intellectual property, and pharmaceutical regulation. Chapter 11 is available open access under a Creative Commons Attribution 4.0 International License via link.springer.com.

ISBN: 9789811678141$q(electronic bk.)

Standard No.: 10.1007/978-981-16-7814-1doiSubjects--Topical Terms:

925109
Antitrust law
--Japan.

LC Class. No.: KNX3242

Dewey Class. No.: 343.520721

Competition law and policy in the Japanese pharmaceutical sector
LDR:04235nmm a2200337 a 4500 001 623101
003 DE-He213
005 20220208091716.0
006 m d
007 cr nn 008maaau
008 221209s2022 si s 0 eng d
020 $a 9789811678141$q(electronic bk.)
020 $a 9789811678134$q(paper)
024 7 $a 10.1007/978-981-16-7814-1 $2 doi
035 $a 978-981-16-7814-1
040 $a GP $c GP
041 0 $a eng
050 4 $a KNX3242
072 7 $a LNCB $2 bicssc
072 7 $a LAW014000 $2 bisacsh
072 7 $a LNCB $2 thema
082 0 4 $a 343.520721 $2 23
090 $a KNX3242 $b .C737 2022
245 0 0 $a Competition law and policy in the Japanese pharmaceutical sector $h [electronic resource] / $c edited by Akira Negishi, Masako Wakui, Naoko Mariyama.
260 $a Singapore : $b Springer Singapore : $b Imprint: Springer, $c 2022.
300 $a xxi, 245 p. : $b ill., digital ; $c 24 cm.
490 1 $a Kobe University monograph series in social science research, $x 2524-5058
505 0 $a Preface -- PART I　HEALTHCARE AND PHARMACEUTICALS: INNOVATION AND REGULATION IN JAPAN -- Regulation and Competition in the Pharmaceutical Industry in Japan -- Competition and Cooperation: Building a Sustainable Healthcare Delivery System in a Society with a Declining Population -- Drug Regulation in Japan -- Collaboration between the Patent System and Pharmaceutical Regulations for Drug-discovery Innovation in Japan -- Corruption and Conflicts of Interest in the Pharmaceutical Market: Regulation of Pharmaceutical Companies' Gift-giving Practices -- PART II THE JAPANESE ANTIMONOPOLY ACT AND ITS RELATION TO THE PHARMACEUTICAL INDUSTRY -- Antimonopoly Act and Its Application to the Pharmaceutical Industry in Japan -- Horizontal Cooperation and Alliances amongst Pharmaceutical Companies and the Japanese Antimonopoly Act -- Merger Regulations in the Japanese Pharmaceutical Industry -- Pay-for-delay Agreements in Japan -- No Challenge Clauses in the Pharmaceutical Industry in Japan -- Will Authorised Biologics deter Biosimilars? -Utilising JFTC's expertise in drug pricing -- PART III AN ECONOMIC ANALYSIS OF THE PHARMACEUTICAL INDUSTRY AND TRADE PRACTICES IN JAPAN -- The Pharmaceutical Industry in Japan: A History of Its Development -- Trade Practices in the Japanese Pharmaceutical Market: A Simulation Analysis of Improvement Policies.
520 $a This is the first book published that focuses on competition law and policy in the Japanese pharmaceutical sector. It consists of chapters written and edited by academics who research the industry from various perspectives, including economics, competition law, pharmaceutical regulations, and intellectual property law. Competition policies involving pharmaceutical products attract attention from academics and policymakers worldwide. The pharmaceutical industry is regulated by drug laws that vary from country to country and are affected by differing practices and industrial structures. The book begins by examining drug regulations and trade practices in the industry that are peculiar to Japan and its healthcare system. It then presents the Japanese Antimonopoly Act and cases involving it, and discussions of current competition law issues in the Japanese pharmaceutical industry. The book also discusses innovation and intellectual property and economic analyses of pharmaceutical regulations and drug discovery. The chapters include comparative studies on Japanese regulations vs. those in the European Union and the United States. Japan is one of the biggest pharmaceutical markets in the world. With this in mind, the book provides "one-stop shopping" for anyone interested in pharmaceutical regulations in the country. Covering the basics but extending to in-depth explorations of complex problems, this book appeals not only to students and academics, pharmaceutical companies and regulators, but also to those dealing with real-world policy issues that encompass competition policy, intellectual property, and pharmaceutical regulation. Chapter 11 is available open access under a Creative Commons Attribution 4.0 International License via link.springer.com.
650 0 $a Antitrust law $z Japan. $3 925109
650 0 $a Pharmaceutical industry $z Japan. $3 925110
650 0 $a Drugs $x Law and legislation $z Japan. $3 925111
650 1 4 $a Commercial Law. $3 274030
650 2 4 $a Medical Law. $3 275623
650 2 4 $a IT Law, Media Law, Intellectual Property. $3 823867
650 2 4 $a Health Care. $3 913433
650 2 4 $a Law and Economics. $3 274032
650 2 4 $a Private International Law, International and Foreign Law, Comparative Law. $3 913280
700 1 $a Negishi, Akira. $3 925106
700 1 $a Wakui, Masako. $3 925107
700 1 $a Mariyama, Naoko. $3 925108
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer Nature eBook
830 0 $a Kobe University monograph series in social science research. $3 833678
856 4 0 $u https://doi.org/10.1007/978-981-16-7814-1
950 $a Law and Criminology (SpringerNature-41177)